Mettler-Toledo International (NYSE:MTD) Stock Price Expected to Rise, Barclays Analyst Says

Mettler-Toledo International (NYSE:MTD) had its price target increased by Barclays from $1,700.00 to $1,900.00 in a report issued on Monday, Benzinga reports. The firm currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price objective would suggest a potential upside of 10.07% from the stock’s current price.

Other analysts also recently issued reports about the company. Jefferies Financial Group raised their price objective on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Stifel Nicolaus raised their target price on Mettler-Toledo International from $1,600.00 to $1,900.00 and gave the company a “buy” rating in a report on Monday. Rothschild & Co Redburn started coverage on shares of Mettler-Toledo International in a research note on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price target on the stock. Morgan Stanley increased their price target on shares of Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 13th. Finally, UBS Group initiated coverage on shares of Mettler-Toledo International in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 price objective for the company. Six analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $1,555.38.

Mettler-Toledo International Trading Up 0.2%

Shares of MTD stock traded up $3.99 during trading on Monday, hitting $1,726.14. 48,230 shares of the stock traded hands, compared to its average volume of 183,745. Mettler-Toledo International has a 52-week low of $1,023.05 and a 52-week high of $1,806.58. The firm has a market capitalization of $34.59 billion, a P/E ratio of 37.38, a price-to-earnings-growth ratio of 3.46 and a beta of 1.16. The firm’s fifty day moving average price is $1,524.65 and its 200-day moving average price is $1,345.95. The company has a debt-to-equity ratio of 25.28, a current ratio of 1.10 and a quick ratio of 0.75.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share for the quarter, topping the consensus estimate of $12.13 by $0.44. The company had revenue of $1.09 billion during the quarter, compared to analyst estimates of $1.07 billion. Mettler-Toledo International had a return on equity of 15,012.71% and a net margin of 22.25%. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the business posted $11.15 earnings per share. As a group, research analysts forecast that Mettler-Toledo International will post 47.49 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, CEO Patrick Kaltenbach sold 942 shares of the company’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the sale, the chief executive officer owned 4,480 shares of the company’s stock, valued at approximately $6,384,000. This represents a 17.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.71% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. National Pension Service increased its holdings in Mettler-Toledo International by 7.9% during the 2nd quarter. National Pension Service now owns 39,696 shares of the medical instruments supplier’s stock worth $50,712,000 after purchasing an additional 2,916 shares during the period. Aware Super Pty Ltd as trustee of Aware Super acquired a new stake in Mettler-Toledo International in the 1st quarter valued at about $26,372,000. Bank of America Corp DE purchased a new position in shares of Mettler-Toledo International in the 2nd quarter valued at about $240,817,000. Corient Private Wealth LP boosted its stake in shares of Mettler-Toledo International by 421.7% in the 2nd quarter. Corient Private Wealth LP now owns 26,147 shares of the medical instruments supplier’s stock valued at $33,402,000 after buying an additional 21,135 shares during the period. Finally, Jefferies Financial Group Inc. purchased a new position in shares of Mettler-Toledo International in the 2nd quarter valued at about $1,283,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes.

The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.